|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients显示文摘 | Pescovitz MD Vincenti F Hart M | 2007 | Br J Clin Pharmacol2007，64，6： | 1 |
| 2 | B cells:a rational target in alloanti-body-mediated solid organ transplantation rejection显示文摘 | PESCOVITZ M D | 2006 | Clin Transplant2006，20，： | 1 |
| 3 | Rituximab,an Anti-CD20mono-clonal antibody:history and mechanism of action显示文摘 | PESCOVITZ M D | 2006 | Am J Transplant2006，6，： | 1 |
| 4 | Murine anti-swine T4 and T8 monoclonal antibodies:Distribution and effects on proliferative and cytotoxie T cells 显示文摘 | Pescovitz M D Lunney J K Sachs D H | 1985 | J Immunol1985，134，： | 1 |
| 5 | Porcine peripheral blood CD4^+/CD8^+ dual expressing T-cells显示文摘 | Pescovitz M D Sakopoulos A G Gaddy J A | 1994 | Vet Immunol Immunopathol1994，43，13： | 1 |
| 6 | Immunosuppressive the-rapy and post-transplantation diarrhea 显示文摘 | PESCOVITZ M D NAVARRO M T | 2001 | Clin Transplantation2001，15，4： | 1 |
| 7 | The arteriovenous fistula for hemodialysis access:gold standard or archaic relic?显示文摘 | Leapman SB Boyle M Pescovitz MD | 1996 | Am Surg1996，62，： | 1 |
| 8 | Urinary actin,in-terleukin-6,and interleukin-8 may predict sustained ARF after ischemic injury in renal allografts显示文摘 | Kwon O Molitoris BA Pescovitz M | 2003 | Am J Kidney Dis2003，41，5： | 1 |
| 9 | Tissue-specific ex-pression and structure of a divergent member of a class I MHC genefamily显示文摘 | Ehrlich R Lifshitz R Pescovitz M D | 1987 | J Immunol1987，139，： | 1 |
| 10 | Explai-ning variability in mycophenolic acid exposure to optimize myco-phenolate mofetil dosing: A population pharmacokinetic meta-a-nalysis of mycophenolic acid in renal transplant recipients 显示文摘 | HEST R M MATHOT H A A PESCOVITZ M D | 2006 | JAm Soc Nephrolf2006，17，3： | 1 |
| 11 | Formulary considerations for drugs used to prevent cytome-galovirus disease显示文摘 | Pescovitz M D | 2003 | Am J Health Syst Pharm2003，60，8： | 1 |
| 12 | Rituximab, an anti-CD20 monoclonal anti- body: history and mechanism of action显示文摘 | Pescovitz M D | 2006 | Am J Transplanta- tion2006，6，： | 1 |
| 13 | The effect of gastric pH modulators on the pharmaeokinetics of myeopheno- late mofetil (MMF) in de novo renal transplant patients 显示文摘 | VAN GELDER T PESCOVITZ M ELZEIN H | 2004 | Presented at the International Congress of the Transplantation2004，2004，： | 1 |
| 14 | Increased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody (rituximab) therapy in type 1 diabetes显示文摘 | Herold K C Pescovitz M D McGee P | 2011 | J lmmunol2011，187，4： | 1 |
| 15 | Rituximab,an anti-CD20 monoclonal antibody:history and mechanism of action显示文摘 | Pescovitz M D | 2006 | Am J Transplantation2006，6，： | 1 |
| 16 | Urinary actin, interleukin-6, and interleukin-8 may predict sustained ARF after injury in renal grafts显示文摘 | Kwon O Molitoris BA Pescovitz M | 2003 | Am J Kidney Dis2003，41，5： | 1 |
| 17 | Phenotypic and functional characterization of pig lymphocyte populations显示文摘 | Lunney J Pescovitz M | 1987 | Vet Immunol Immunopathol1987，17，14： | 1 |
| 18 | Phenotypic and functional characterization of pig lymphocyte populations显示文摘 | Lunney J K Pescovitz M D | 1987 | Vet Immunol Immunopathol1987，17，1： | 1 |
| 19 | Rituximab, an anti cd20 monoclonal antibody: history and mechanism of action 显示文摘 | PESCOVITZ M D | 2006 | Am J Transplant2006，6，51： | 1 |
| 20 | Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients 显示文摘 | Pescovitz M Govani M | 2001 | Am J Kidney Dis2001，38，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员